Safety, tolerability and symptom outcomes associated with L-carnitine supplementation in patients with cancer, fatigue, and carnitine deficiency: a phase I/II study
Choosing the right GLP-1 program requires evaluating three dimensions: medication formulation and dosing flexibility, provider support and clinical monitoring, and access to biomarker or genetic context that personalizes treatment decisions
Give your body a boost with B12
Prime Therapeutics , GLP-1 Pipeline Update: February 2026 ( [47] )
Wegovy is also FDA-approved to reduce the risk of cardiovascular events in adults with established cardiovascular disease and either overweight or obesity
This is especially relevant for GLP-1 users who report feeling like the stool is right there but will not come out, or who experience excessive straining despite having soft stool